Virtu Financial’s Nephros NEPH Stock Holding History

Virtu Financial’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,089	Closed	-$16K	–	1972
2022 Q3	$16K	Buy	+17,089	New	+$24.2K	﹤0.01%	1448

Other funds holding NEPH

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's NEPH Position: Q4 2022 in Review

Virtu Financial sold out of Nephros (NEPH) in Q4 2022, closing a stake of 17,089 shares — an estimated $16K sold.

Virtu Financial first reported a position in NEPH in Q3 2022 and held it in 1 quarter. The position peaked at $16K in Q3 2022. 19 funds tracked by Wall St. Rank hold NEPH as of Q4 2022.

Virtu Financial reported no remaining Nephros position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 17,089 Nephros shares in Q4 2022, an estimated $16K.
Virtu Financial first reported a position in Nephros in Q3 2022 and held it in 1 quarter.
Virtu Financial's Nephros position peaked at $16K in Q3 2022.
19 funds tracked by Wall St. Rank held Nephros as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.